Goodpasture disease: Difference between revisions
No edit summary |
|||
| Line 30: | Line 30: | ||
{{SK}} Anti-GBM nephritis with pulmonary hemorrhage; antiglomerular basement membrane disease; Goodpasture’s syndrome | {{SK}} Anti-GBM nephritis with pulmonary hemorrhage; antiglomerular basement membrane disease; Goodpasture’s syndrome | ||
==[[Goodpasture syndrome overview|Overview]]== | |||
==[[Goodpasture syndrome historical perspective|Historical Perspective]]== | |||
==[[Goodpasture syndrome classification|Classification]]== | |||
==[[Goodpasture syndrome pathophysiology|Pathophysiology]]== | |||
==[[Goodpasture syndrome causes|Causes]]== | |||
==[[Goodpasture syndrome differential diagnosis|Differentiating Goodpasture syndrome from other Diseases]]== | |||
==[[Goodpasture syndrome epidemiology and demographics|Epidemiology and Demographics]]== | |||
==[[Goodpasture syndrome risk factors|Risk Factors]]== | |||
==[[Goodpasture syndrome screening|Screening]]== | |||
==[[Goodpasture syndrome natural history|Natural History, Complications and Prognosis]]== | |||
==[[Goodpasture syndrome diagnosis|Diagnosis]]== | |||
[[Goodpasture syndrome history and symptoms|History and Symptoms]] | [[Goodpasture syndrome physical examination|Physical Examination]] | [[Goodpasture syndrome laboratory tests|Laboratory Findings]] | [[Goodpasture syndrome chest x ray|Chest X Ray]] | [[Goodpasture syndrome CT|CT]] | [[Goodpasture syndrome ultrasound|Ultrasound]] | [[Goodpasture syndrome other imaging findings|Other Imaging Findings]] | [[Goodpasture syndrome other diagnostic studies|Other Diagnostic Studies]] | |||
==Treatment== | |||
[[Goodpasture syndrome medical therapy|Medical Therapy]] | [[Goodpasture syndrome surgery|Surgery]] | [[Goodpasture syndrome primary prevention|Primary Prevention]] | [[Goodpasture syndrome secondary prevention|Secondary Prevention]] | [[Goodpasture syndrome cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Goodpasture syndrome future or investigational therapies|Future or Investigational Therapies]] | |||
==Case Studies== | |||
:[[Goodpasture syndrome case study one|Case #1]] | |||
== Related Chapters == | == Related Chapters == | ||
Revision as of 18:48, 24 September 2012
| Goodpasture disease | |
| ICD-10 | M31.0 (ILDS M31.010) |
|---|---|
| ICD-9 | 446.21 |
| OMIM | 233450 |
| DiseasesDB | 5363 |
| MedlinePlus | 142 |
| MeSH | D019867 |
|
Goodpasture syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Goodpasture disease On the Web |
|
American Roentgen Ray Society Images of Goodpasture disease |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Synonyms and keywords: Anti-GBM nephritis with pulmonary hemorrhage; antiglomerular basement membrane disease; Goodpasture’s syndrome
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Goodpasture syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Related Chapters
External links
GBM antibodies: immunofluorescence image
Template:Diseases of the musculoskeletal system and connective tissue